Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24960
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLANGIE, Sabine-
dc.contributor.authorMoisse, Matthieu-
dc.contributor.authorDeclerck, Ken-
dc.contributor.authorKoppen, Gudrun-
dc.contributor.authorGodderis, Lode-
dc.contributor.authorVanden Berghe, Wim-
dc.contributor.authorDrury, Stacy-
dc.contributor.authorDE BOEVER, Patrick-
dc.date.accessioned2017-10-09T14:31:30Z-
dc.date.available2017-10-09T14:31:30Z-
dc.date.issued2017-
dc.identifier.citationBASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 121(S3), p. 93-101-
dc.identifier.issn1742-7835-
dc.identifier.urihttp://hdl.handle.net/1942/24960-
dc.description.abstractIs it not more comfortable to spit saliva in a tube than to be pricked with a needle to draw blood to analyse your health and disease risk? Many patients, study participants and (parents of) young children undoubtedly prefer non-invasive and convenient procedures. Such procedures increase compliance rates especially for longitudinal prospective studies. Saliva is an attractive biofluid providing good quality DNA to study epigenetic mechanisms underlying disease across development. In this MiniReview, we will describe the different applications of saliva in the field of epigenetics, focusing on genomewide methylation analysis. Advantages of the use of saliva and its comparability with blood will be discussed, as will the challenges in data processing and interpretation. Knowledge gaps will be identified and suggestions given on how to improve the analysis, making saliva 'the' biofluid of choice for future biomarker initiatives in many different epidemiological and public health studies.-
dc.description.sponsorshipSL is the beneficiary of the Cefic-LRI Innovative Science Award 2013 and of a postdoctoral fellowship [12L5216N; http://www.fwo.be/] provided by The Research Foundation-Flanders (FWO) and the Flemish Institute of Technological Research (VITO). PDB is recipient of a Bill & Melinda Gates Foundation Grand Challenges Exploration Grant (OPP119403) in the field of saliva biomarker discovery, enabling collaboration with SD. WVB and KDK are supported by FWO grants G079614N and G059713N and BOF NOI/DOCPRO grants (UA). The work by LG was supported via an FWO-VITO PhD grant (grant number 11B1812N). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.-
dc.language.isoen-
dc.publisherWILEY-
dc.rights©2016 The Authors.Basic & Clinical Pharmacology & Toxicologypublished by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT(former Nordic Pharmacological Society)This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use,distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes-
dc.titleSalivary DNA Methylation Profiling: Aspects to Consider for Biomarker Identification-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateAUG 14-18, 2016-
local.bibliographicCitation.conferencenameAnnual Meeting of the European-Environmental-Mutagenesis-and-Genomics-Society (EEMGS)-
local.bibliographicCitation.conferenceplaceCopenhagen, DENMARK-
dc.identifier.epage101-
dc.identifier.issueS3-
dc.identifier.spage93-
dc.identifier.volume121-
local.format.pages9-
local.bibliographicCitation.jcatA1-
dc.description.notes[Langie, Sabine A. S.; Koppen, Gudrun; De Boever, Patrick] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium. [Langie, Sabine A. S.; De Boever, Patrick] Hasselt Univ, Fac Sci, Diepenbeek, Belgium. [Moisse, Matthieu] Katholieke Univ Leuven, VIB Vesalius Res Ctr, Leuven, Belgium. [Declerck, Ken; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Lab Prot Chem Prote & Epigenet Signaling, Antwerp, Belgium. [Godderis, Lode] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Ctr Environm & Hlth, Leuven, Belgium. [Godderis, Lode] IDEWE, External Serv Prevent & Protect Work, Heverlee, Belgium. [Drury, Stacy] Tulane Univ, Inst Brain, New Orleans, LA 70118 USA. [Drury, Stacy] Tulane Univ, Sch Med, Dept Psychiat & Behav Sci, 1430 Tulane Ave, New Orleans, LA 70112 USA.-
local.publisher.placeHOBOKEN-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1111/bcpt.12721-
dc.identifier.isi000411036200011-
item.fulltextWith Fulltext-
item.contributorLANGIE, Sabine-
item.contributorMoisse, Matthieu-
item.contributorDeclerck, Ken-
item.contributorKoppen, Gudrun-
item.contributorGodderis, Lode-
item.contributorVanden Berghe, Wim-
item.contributorDrury, Stacy-
item.contributorDE BOEVER, Patrick-
item.fullcitationLANGIE, Sabine; Moisse, Matthieu; Declerck, Ken; Koppen, Gudrun; Godderis, Lode; Vanden Berghe, Wim; Drury, Stacy & DE BOEVER, Patrick (2017) Salivary DNA Methylation Profiling: Aspects to Consider for Biomarker Identification. In: BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 121(S3), p. 93-101.-
item.accessRightsOpen Access-
item.validationecoom 2018-
crisitem.journal.issn1742-7835-
crisitem.journal.eissn1742-7843-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
Langie_et_al-2017-Basic_&_Clinical_Pharmacology_&_Toxicology.pdfPublished version343.15 kBAdobe PDFView/Open
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.